Trial Profile
Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Jun 2012
Price :
$35
*
At a glance
- Drugs Sonedenoson (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- 24 May 2012 New trial record